Compritol-Based Nanostrucutured Lipid Carriers (NLCs) for Augmentation of Zolmitriptan Bioavailability via the Transdermal Route: In Vitro Optimization, Ex Vivo Permeation, In Vivo Pharmacokinetic Study
- Citation:
- Hassan, D. H., J. N. Shohdy, D. A. El-Setouhy, M. El-Nabarawi, and M. J. Naguib,
"Compritol-Based Nanostrucutured Lipid Carriers (NLCs) for Augmentation of Zolmitriptan Bioavailability via the Transdermal Route: In Vitro Optimization, Ex Vivo Permeation, In Vivo Pharmacokinetic Study",
pharmaceutics, vol. 14, pp. 1484, 2022.
